Brand Share-of-Voice Monitor

Track and analyze brand mentions across different channels

Brand Share-of-Voice Monitor for Pharmaceutical Brands

Track and analyze brand mentions across different channels including social media, medical journals, news, conferences, and patient forums.

Lumara - PharmaCorp
Lumara is a breakthrough immunotherapy treatment for advanced melanoma, showing promising results in clinical trials.
Category: Oncology
Launch Date: 6/15/2023
CardioPlus - MediTech Solutions
CardioPlus is a next-generation blood pressure medication with fewer side effects than traditional treatments.
Category: Cardiovascular
Launch Date: 3/10/2022
NeuroRestore - BioPharma Innovations
NeuroRestore is a novel treatment for multiple sclerosis that helps repair damaged nerve cells.
Category: Neurology
Launch Date: 11/5/2023
RespiraClear - PharmaCorp
RespiraClear is an inhaled corticosteroid for severe asthma that provides 24-hour symptom relief.
Category: Respiratory
Launch Date: 9/20/2022
DermaHeal - SkinCare Pharmaceuticals
DermaHeal is a topical treatment for psoriasis that targets the underlying inflammatory response.
Category: Dermatology
Launch Date: 1/15/2023

Twitter - 3/15/2024
Exciting news! New clinical trial results for #Lumara show 65% improvement in progression-free survival for melanoma patients. #Oncology #CancerResearch
Channel: social_media
Sentiment: positive
Journal of Clinical Oncology - 3/10/2024
Phase III clinical trial results for Lumara (immunotherapy) demonstrate significant improvement in overall survival compared to standard of care in advanced melanoma patients.
Channel: medical_journals
Sentiment: positive
PharmaTimes - 3/8/2024
PharmaCorp's Lumara receives FDA fast-track designation for advanced melanoma treatment.
Channel: news
Sentiment: neutral
ASCO Annual Meeting - 2/20/2024
Oral presentation: Lumara demonstrates promising results in combination therapy for advanced melanoma.
Channel: conferences
Sentiment: positive
CancerConnect - 3/12/2024
Has anyone experienced severe side effects with Lumara? My doctor recommended it but I'm concerned about the risks.
Channel: patient_forums
Sentiment: negative

Lumara has 42 total mentions across 5 different channels.

social_media: 15 mentions (35.7%)
medical_journals: 8 mentions (19.0%)
news: 10 mentions (23.8%)
conferences: 5 mentions (11.9%)
patient_forums: 4 mentions (9.5%)

Brands

Lumara

Oncology

PharmaCorp

Launched: 6/15/2023

Oncology

Description

Lumara is a breakthrough immunotherapy treatment for advanced melanoma, showing promising results in clinical trials.

Share of Voice Analysis

Total Mentions

social media15 (35.7%)

medical journals8 (19.0%)

news10 (23.8%)

conferences5 (11.9%)

patient forums4 (9.5%)